Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,759 | 28,378 | 31,987 | 35,974 | 42,669 |
| TOTAL | $25,547 | $36,022 | $32,487 | $36,525 | $43,297 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $25,547 | $36,022 | $32,487 | $36,525 | $43,297 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,153 | 3,961 | 1,846 | 902 | 929 |
| Accrued Expenses | 1,258 | 3,737 | 681 | 398 | 327 |
| TOTAL | $5,411 | $7,699 | $2,527 | $1,299 | $1,256 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,411 | $7,699 | $2,527 | $1,299 | $1,256 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,005 | 8,217 | 8,164 | 8,164 | 8,164 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -63,792 | -54,055 | -50,960 | -43,339 | -34,620 |
| TOTAL | $20,136 | $28,324 | $29,961 | $35,226 | $42,040 |
| Total Liabilities And Equity | $25,547 | $36,022 | $32,487 | $36,525 | $43,297 |